Financials data is unavailable for this security.
View more
Year on year Theralase Technologies Inc had revenues fall -6.00% from 1.14m to 1.07m, though the company grew net income from a loss of 5.24m to a smaller loss of 4.57m.
Gross margin | 49.00% |
---|---|
Net profit margin | -478.72% |
Operating margin | -478.72% |
Return on assets | -130.29% |
---|---|
Return on equity | -238.55% |
Return on investment | -204.79% |
More ▼
Cash flow in CADView more
In 2023, cash reserves at Theralase Technologies Inc fell by 1.46m. Cash Flow from Financing totalled 2.65m or 247.16% of revenues. In addition the company used 4.07m for operations while cash used for investing totalled 37.27k.
Cash flow per share | -0.0182 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0069 |
---|---|
Tangible book value per share | 0.0069 |
More ▼
Balance sheet in CADView more
Current ratio | 1.21 |
---|---|
Quick ratio | 0.7723 |
Total debt/total equity | 0.2059 |
---|---|
Total debt/total capital | 0.1707 |
More ▼